Masimo Announces FDA 510(k) Clearance of Radius VSM™
Masimo (NASDAQ: MASI) today announced that Radius VSM™ , a patient-worn, continuous multi-parameter vital signs monitor, has received FDA 510(k) clearance.
- Masimo (NASDAQ: MASI) today announced that Radius VSM™ , a patient-worn, continuous multi-parameter vital signs monitor, has received FDA 510(k) clearance.
- Designed on a modular platform, Radius VSM allows clinicians to monitor a wide variety of physiological measurements, including Masimo SET® pulse oximetry , noninvasive blood pressure, temperature, respiration rate, and electrocardiography (ECG).
- By combining the reliability and accuracy of larger bedside monitors with the comfort and freedom of a wearable device, Radius VSM allows ambulation and movement while ensuring patients remain continuously monitored.
- From a technical perspective, we had no doubt about the reliability of the solution as we have been working with Masimo for many years now.